Form 4: Serina Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Farrell Simon, a Director of Serina Therapeutics, Inc., received 30,500 shares of common stock on July 22, 2026.
Summary
- Grant/award: acquired 30,500 Stock Option (right to buy) on July 22, 2026; holds 30,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Farrell Simon — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Grant/award | Stock Option (right to buy) | 30,500 | — | — | 30,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Grant/award (30,500 shares) |
Keywords
insider transaction, Form 4, SER, Serina Therapeutics, Inc., neutral, Farrell Simon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.